GSA Capital Partners’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $374K | Buy |
5,287
+184
| +4% | +$9.94K | 0.02% | 1182 |
|
|
2026
Q1 | $267K | Buy |
+5,103
| New | +$306K | 0.02% | 1312 |
|
|
2025
Q4 | – | Sell |
-7,803
| Closed | -$434K | – | 2084 |
|
|
2025
Q3 | $434K | Buy |
7,803
+2,569
| +49% | +$138K | 0.04% | 951 |
|
|
2025
Q2 | $269K | Buy |
+5,234
| New | +$263K | 0.02% | 1330 |
|
|
2023
Q4 | – | Sell |
-5,102
| Closed | -$347K | – | 1919 |
|
|
2023
Q3 | $347K | Buy |
+5,102
| New | +$403K | 0.03% | 1001 |
|
|
2023
Q2 | – | Sell |
-11,963
| Closed | -$888K | – | 1938 |
|
|
2023
Q1 | $888K | Buy |
+11,963
| New | +$922K | 0.09% | 383 |
|
|
2022
Q4 | – | Sell |
-7,448
| Closed | -$529K | – | 1876 |
|
|
2022
Q3 | $529K | Buy |
+7,448
| New | +$644K | 0.07% | 529 |
|
|
2020
Q4 | – | Sell |
-5,600
| Closed | -$347K | – | 1589 |
|
|
2020
Q3 | $347K | Buy |
+5,600
| New | +$364K | 0.06% | 639 |
|
|
2020
Q1 | – | Sell |
-27,632
| Closed | -$1.52M | – | 1540 |
|
|
2019
Q4 | $1.52M | Buy |
27,632
+5,288
| +24% | +$277K | 0.18% | 69 |
|
|
2019
Q3 | $1.09M | Sell |
22,344
-20,428
| -48% | -$1.02M | 0.15% | 131 |
|
|
2019
Q2 | $2.23M | Sell |
42,772
-10,064
| -19% | -$507K | 0.25% | 31 |
|
|
2019
Q1 | $2.62M | Buy |
52,836
+8,800
| +20% | +$396K | 0.27% | 38 |
|
|
2018
Q4 | $1.59M | Buy |
44,036
+6,344
| +17% | +$265K | 0.18% | 86 |
|
|
2018
Q3 | $1.92M | Buy |
37,692
+20,092
| +114% | +$890K | 0.11% | 263 |
|
|
2018
Q2 | $651K | Sell |
17,600
-4,400
| -20% | -$168K | 0.03% | 1012 |
|
|
2018
Q1 | $831K | Buy |
+22,000
| New | +$777K | 0.04% | 780 |
|
|
2017
Q4 | – | Sell |
-11,600
| Closed | -$351K | – | 1809 |
|
|
2017
Q3 | $351K | Sell |
11,600
-11,600
| -50% | -$344K | 0.02% | 1169 |
|
|
2017
Q2 | $682K | Sell |
23,200
-107,200
| -82% | -$2.93M | 0.04% | 802 |
|
|
2017
Q1 | $3.31M | Buy |
130,400
+6,840
| +6% | +$177K | 0.18% | 78 |
|
|
2016
Q4 | $3.18M | Buy |
123,560
+16,716
| +16% | +$439K | 0.19% | 64 |
|
|
2016
Q3 | $2.92M | Sell |
106,844
-22,184
| -17% | -$609K | 0.16% | 109 |
|
|
2016
Q2 | $3.64M | Buy |
129,028
+27,968
| +28% | +$719K | 0.2% | 51 |
|
|
2016
Q1 | $2.39M | Sell |
101,060
-58,304
| -37% | -$1.28M | 0.15% | 128 |
|
|
2015
Q4 | $3.59M | Buy |
159,364
+45,636
| +40% | +$1.04M | 0.18% | 82 |
|
|
2015
Q3 | $2.63M | Sell |
113,728
-82,580
| -42% | -$2.07M | 0.13% | 164 |
|
|
2015
Q2 | $4.83M | Buy |
196,308
+8,456
| +5% | +$211K | 0.19% | 57 |
|
|
2015
Q1 | $4.71M | Buy |
187,852
+70,400
| +60% | +$1.67M | 0.19% | 62 |
|
|
2014
Q4 | $2.71M | Buy |
117,452
+15,324
| +15% | +$351K | 0.19% | 70 |
|
|
2014
Q3 | $2.39M | Buy |
102,128
+30,400
| +42% | +$713K | 0.13% | 162 |
|
|
2014
Q2 | $1.66M | Buy |
71,728
+11,588
| +19% | +$256K | 0.07% | 362 |
|
|
2014
Q1 | $1.28M | Buy |
60,140
+8,468
| +16% | +$191K | 0.09% | 229 |
|
|
2013
Q4 | $1.22M | Sell |
51,672
-7,324
| -12% | -$159K | 0.1% | 253 |
|
|
2013
Q3 | $1.18M | Buy |
58,996
+23,588
| +67% | +$448K | 0.09% | 269 |
|
|
2013
Q2 | $611K | Buy |
+35,408
| New | +$588K | 0.07% | 436 |
|
Other funds holding TECH
HI
GSA Capital Partners's TECH Position: Q2 2026 in Review
GSA Capital Partners increased its Bio-Techne (TECH) stake by 3.6% in Q2 2026, buying an estimated $9.94K and bringing the position to 5,287 shares worth $374K. The position accounts for 0.02% of the portfolio, ranked #1182.
GSA Capital Partners first reported a position in TECH in Q2 2013 and has held it in 34 quarters since. The position peaked at $4.83M in Q2 2015. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- GSA Capital Partners held 5,287 shares of Bio-Techne worth $374K as of Q2 2026.
- GSA Capital Partners bought 184 Bio-Techne shares in Q2 2026, an estimated $9.94K.
- Bio-Techne made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1182 holding.
- GSA Capital Partners first reported a position in Bio-Techne in Q2 2013 and has held it in 34 quarters since.
- GSA Capital Partners's Bio-Techne position peaked at $4.83M in Q2 2015.
- 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.